To help limit the spread of COVID-19, National General is waiving 100% of all out-of-pocket costs for COVID-19 diagnostic tests and will ease access for customers seeking diagnostic testing. This waiver will extend to all National General Short Term Medical customers and will be made available to employers in the National General Benefits Solutions Program. As part of the effort regarding COVID-19 diagnostic testing, National General will:
- Waive all member cost sharing for COVID-19 diagnostic tests and related services, including the associated office visit, emergency room, or urgent care charges. The waiver applies any out-of-pocket costs, including deductibles, copays, and co-insurance for diagnostic testing related to COVID-19.
- Waive all prior authorization requirements as it relates to COVID-19 diagnostic testing.
- Allow early refills and up to a 90-day supply of a member’s prescription drugs in the event of hardship related to COVID-19.
Customers concerned about exposure to COVID-19 should contact their healthcare provider or state health department. National General’s customer service call center will be available to assist if customers have any questions about COVID-19 testing-related services.
For additional information, please visit: https://natgenhealth.com/
Who should be tested for COVID-19?
As of 3/8/2020, the Centers for Disease Control (“CDC”) recommends that anyone with symptoms of COVID-19, returning from a Centers for Disease Control-designated “Level 2” or “Level 3” advisory area, or who has been in contact with someone who is suspected or confirmed of having the coronavirus within the last 14 days, should be tested. Any individual who suspects that they may have been exposed to the coronavirus or is exhibiting symptoms should consult with their health care provider to make the appropriate testing recommendation, in line with CDC guidelines.
Please sign in to leave a comment.